Foghorn Therapeutics Inc

NASDAQ:FHTX   2:02:13 PM EDT
6.42
-0.24 (-3.60%)
Earnings Announcements

Foghorn Therapeutics Provides Third Quarter Financial Results

Published: 11/08/2022 12:43 GMT
Foghorn Therapeutics Inc (FHTX) - Foghorn Therapeutics Provides Third Quarter 2022 Financial and Corporate Update.
Foghorn Therapeutics .
- Cash, Cash Equivalents & Marketable Securities of $373.5 Million, As of Sept 30, Provides Significant Cash Runway Into 2025.
Qtrly Loss per Share $0.62.
Q3 Earnings per Share View $-0.62, Revenue View $9.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $8.85 Million
Adjusted EPS is expected to be -$0.62

Next Quarter Revenue Guidance is expected to be $4.22 Million
Next Quarter EPS Guidance is expected to be -$0.78

More details on our Analysts Page.